For crystalline, semi-crystalline, and even amorphous samples, Bruker X-ray diffractometers can produce beam-optimized scans to support pharmaceutical product development. The instrument family provides both multipurpose and dedicated solutions for more specific applications in materials characterization.
Pharmaceutical development brings new challenges to light: crystalline polymorphs, thin-films, excipient analysis. Integration of this important physical characterization data underlies product formulation, consistency, and eventual FDA submission documentation. Using the Tetra Data Platform allows for integration of these data against other parameters such as mass spec or DSC to get a fuller picture of your drug substance.
*References here in no way indicate any formal relationship or endorsement by the respective companies
